[go: up one dir, main page]

DE3483855D1 - Verfahren zur herstellung von die vermehrung von malignen krebszellen hemmenden mitteln, und so hergestellte mittel. - Google Patents

Verfahren zur herstellung von die vermehrung von malignen krebszellen hemmenden mitteln, und so hergestellte mittel.

Info

Publication number
DE3483855D1
DE3483855D1 DE8484305099T DE3483855T DE3483855D1 DE 3483855 D1 DE3483855 D1 DE 3483855D1 DE 8484305099 T DE8484305099 T DE 8484305099T DE 3483855 T DE3483855 T DE 3483855T DE 3483855 D1 DE3483855 D1 DE 3483855D1
Authority
DE
Germany
Prior art keywords
malignen
protection
production
cancer cell
products made
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8484305099T
Other languages
English (en)
Inventor
Tomoyuki Tajima
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Koken Co Ltd
Original Assignee
Koken Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Koken Co Ltd filed Critical Koken Co Ltd
Application granted granted Critical
Publication of DE3483855D1 publication Critical patent/DE3483855D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/91—Cell lines ; Processes using cell lines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Mycology (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE8484305099T 1983-07-28 1984-07-26 Verfahren zur herstellung von die vermehrung von malignen krebszellen hemmenden mitteln, und so hergestellte mittel. Expired - Lifetime DE3483855D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP58136794A JPS6028931A (ja) 1983-07-28 1983-07-28 ヒト腎細胞癌由来樹立株細胞の増殖抑制剤の濃縮方法

Publications (1)

Publication Number Publication Date
DE3483855D1 true DE3483855D1 (de) 1991-02-07

Family

ID=15183665

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8484305099T Expired - Lifetime DE3483855D1 (de) 1983-07-28 1984-07-26 Verfahren zur herstellung von die vermehrung von malignen krebszellen hemmenden mitteln, und so hergestellte mittel.

Country Status (3)

Country Link
EP (1) EP0133029B1 (de)
JP (1) JPS6028931A (de)
DE (1) DE3483855D1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59162889A (ja) * 1983-03-07 1984-09-13 Koken Kk 人の悪性腫瘍細胞の増殖抑制剤の製造方法
JPS6028930A (ja) * 1983-07-28 1985-02-14 Koken Kk 人の癌由来細胞の増殖抑制剤の精製方法
EP4086354B1 (de) * 2017-10-05 2024-05-01 Medical Corporation Ichikawa Clinic Verfahren zum herstellen einer zellextraktkomponente oder zusammensetzung, die zytozide aktivität aufweist

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58138383A (ja) * 1982-02-13 1983-08-17 Nippon Shinyaku Co Ltd 生理活性物質の製法
JPS5933223A (ja) * 1982-08-20 1984-02-23 Koken Kk 人の悪性腫瘍細胞増殖抑制剤
JPS59162889A (ja) * 1983-03-07 1984-09-13 Koken Kk 人の悪性腫瘍細胞の増殖抑制剤の製造方法
JPS59204122A (ja) * 1983-05-06 1984-11-19 Koken Kk 人の悪性腫瘍細胞増殖抑制剤の製造方法
JPS6028930A (ja) * 1983-07-28 1985-02-14 Koken Kk 人の癌由来細胞の増殖抑制剤の精製方法
JPS6043386A (ja) * 1983-08-20 1985-03-07 Koken Kk ヒト腎細胞癌由来樹立株細胞の増殖抑制剤の製造方法

Also Published As

Publication number Publication date
EP0133029B1 (de) 1990-12-27
EP0133029A3 (en) 1986-08-13
JPS6028931A (ja) 1985-02-14
EP0133029A2 (de) 1985-02-13
JPH0361649B2 (de) 1991-09-20

Similar Documents

Publication Publication Date Title
DE3689195D1 (de) Verfahren zur Herstellung von Aloe-Erzeugnissen, Erzeugnisse und Zusammensetzungen dazu.
DE3381035D1 (de) Elektrisch miteinander verbundene, intern zusammengeschaltete grossflaechige fotovoltaische zellen und verfahren zur herstellung solcher zellen.
DE3784841D1 (de) Konfektprodukt und verfahren zur herstellung.
DE3671627D1 (de) Tertiaere hydroxyalkylxanthine, verfahren zu ihrer herstellung, die sie enthaltenden arzneimittel und ihre verwendung.
DE3577251D1 (de) Verschlossener bleiakkumulator und verfahren zu seiner herstellung.
DE3677248D1 (de) Bimodale silikonemulsionen, verfahren zur herstellung von silikonemulsionen und die so erhaltenen emulsionen.
ATA30483A (de) Polymerisat- und tensidhaltige präparate, deren herstellung und verwendung
DE3582576D1 (de) Dithioketo-pyrrolo-pyrrole, verfahren zu deren herstellung und verwendung.
DE3674752D1 (de) Alpha, alpha-trehalose-derivat und verfahren zur herstellung davon.
DE3483957D1 (de) Komplexe, verfahren zu ihrer herstellung und dieselben enthaltende formulierungen.
DE3770853D1 (de) Zellenseparator und verfahren zu dessen herstellung.
PT80637A (de) Saatgupellets und verfahren zur herstellung von solchen
DE3687775D1 (de) Polymerpartikel und verfahren zu seiner herstellung.
DE3676655D1 (de) Verbundwerkstoff und verfahren zu seiner herstellung.
DE3677740D1 (de) 2-iod-perfluor-2-methylalkane, verfahren zu deren herstellung und deren verwendung.
DE3484531D1 (de) Tetrahydrobenzotriazole, deren herstellung und verwendung.
DE3576686D1 (de) Chinolinone, verfahren zu ihrer herstellung und die sie enthaltenden pharmazeutischen praeparate.
DE3382247D1 (de) Vinylcarbonsaeure-derivate, ihre herstellung und verwendung.
BR8401354A (pt) Processo para producao de preparados solidos de fotoativador contendo zinco e/ou aluminio-ftalocianinas sulfonadas como fotoativadores,bem como preparado solido de fotoativador assim obtido
LU78814A1 (de) Arzneimittel zur bekaempfung von ulcera,oximether und verfahren zu ihrer herstellung
DE3577372D1 (de) Verfahren zur herstellung von sonnenzellen aus amorphem silizium und das dadurch erzeugte produkt.
DE3579716D1 (de) Verfahren zur herstellung von 2-oxindole-1-carboxamiden und deren zwischenprodukte.
DE3483998D1 (de) Magnesiaklinker und verfahren zu seiner herstellung.
DE3484410D1 (de) Verfahren zur herstellung von die vermehrung von malignen krebszellen hemmenden mitteln, und so erhaltene mittel.
DE3483855D1 (de) Verfahren zur herstellung von die vermehrung von malignen krebszellen hemmenden mitteln, und so hergestellte mittel.

Legal Events

Date Code Title Description
8328 Change in the person/name/address of the agent

Free format text: EISENFUEHR, G., DIPL.-ING. SPEISER, D., DIPL.-ING., 2800 BREMEN STRASSE, J., DIPL.-ING., 8000 MUENCHEN RABUS, W., DR.-ING. BRUEGGE, J., DIPL.-ING., 2800 BREMEN MAIWALD, W., DIPL.-CHEM.DR., 8000 MUENCHEN KLINGHARDT, J., DIPL.-ING., PAT.-ANWAELTE, 2800 BREMEN

8364 No opposition during term of opposition